A risk-prediction model for en bloc resection failure or perforation during endoscopic submucosal dissection of colorectal neoplasms.


Journal

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
ISSN: 1443-1661
Titre abrégé: Dig Endosc
Pays: Australia
ID NLM: 9101419

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 09 10 2019
accepted: 25 12 2019
pubmed: 29 12 2019
medline: 30 6 2021
entrez: 29 12 2019
Statut: ppublish

Résumé

Technical difficulties in colorectal endoscopic submucosal dissections (ESD) result in en bloc resection failure or perforation. This study aimed to develop and validate a risk score for predicting en bloc resection failure or perforation in ESD of colorectal neoplasms. This single-center observational study included 1133 colorectal neoplasms treated with ESD in a Japanese tertiary cancer center. With a derivation set (n = 716), we performed multiple logistic regression to identify significant risk factors for en bloc resection failure or perforation. Based on odds ratios, we developed a risk score, ranging from 0 to 10: 0-1 'low risk' (LR); 2-4 'moderate risk' (MR); and 5-10 'high risk' (HR). An independent validation set comprised prospectively enrolled subjects (n = 417) that underwent ESDs from January 2014 to August 2016. The performance of the risk score for predicting en bloc resection failure or perforation for each risk tier was evaluated. The baseline incidences of en bloc resection failure or perforation were 14.5% and 5.5% in the derivation and validation sets, respectively. We identified the following significant risk factors: endoscopist experience, tumor location, morphology, scope operability, underlying fold, and fold convergence. In the validation set, the incidences of en bloc resection failure or perforation were 0% in the LR tier (n = 62; 14.8%), 2.3% in the MR tier (n = 293; 70.4%), and 25.8% in the HR tier (n = 62; 14.8%) (P < 0.001, Cochran-Armitage trend test). A risk scoring system, which was developed and prospectively validated, can successfully estimate the incidence of en bloc resection failure or perforation.

Identifiants

pubmed: 31883411
doi: 10.1111/den.13619
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

932-939

Informations de copyright

© 2019 Japan Gastroenterological Endoscopy Society.

Références

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018; 68: 394-424.
Imai K, Hotta K, Yamaguchi Y et al. Should laterally spreading tumors granular type be resected en bloc in endoscopic resections? Surg. Endosc. 2014; 28: 2167-73.
Uraoka T, Saito Y, Matsuda T et al. Endoscopic indications for endoscopic mucosal resection of laterally spreading tumours in the colorectum. Gut 2006; 55: 1592-7.
Moss A, Bourke MJ, Williams SJ et al. Endoscopic nucosal resection outcomes and prediction of submucosal cancer from advanced colonic mucosal neoplasia. Gastroenterology 2011; 140: 1909-18.
Zauber AG, Winawer SJ, O'Brien MJ et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N. Engl. J. Med. 2012; 366: 687-96.
Moss A, Williams SJ, Hourigan LF et al. Long-term adenoma recurrence following wide-field endoscopic mucosal resection (WF-EMR) for advanced colonic mucosal neoplasia is infrequent: results and risk factors in 1000 cases from the Australian Colonic EMR (ACE) study. Gut 2015; 64: 57-65.
Hassan C, Repici A, Sharma P et al. Efficacy and safety of endoscopic resection of large colorectal polyps: a systematic review and meta-analysis. Gut 2016; 65: 806-20.
Pohl H, Srivastava A, Bensen SP et al. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology 2013; 144: 74-80.e1.
van Heijningen E-MB, Lansdorp-Vogelaar I, Steyerberg EW et al. Adherence to surveillance guidelines after removal of colorectal adenomas: a large, community-based study. Gut 2015; 64: 1584-92.
Saito Y, Uraoka T, Yamaguchi Y et al. A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video). Gastrointest. Endosc. 2010; 72: 1217-25.
Hotta K, Saito Y, Fujishiro M et al. Impact of endoscopic submucosal dissection for the therapeutic strategy of large colorectal tumors. J. Gastroenterol. Hepatol. 2012; 27: 510-5.
Kobayashi N, Saito Y, Uraoka T, Matsuda T, Suzuki H, Fujii T. Treatment strategy for laterally spreading tumors in Japan: Before and after the introduction of endoscopic submucosal dissection. J. Gastroenterol. Hepatol. 2009; 24: 1387-92.
Oka S, Tanaka S, Saito Y et al. Local recurrence after endoscopic resection for large colorectal neoplasia: a multicenter prospective study in Japan. Am. J. Gastroenterol. 2015; 110: 697-707.
Yoshida N, Wakabayashi N, Kanemasa K et al. Endoscopic submucosal dissection for colorectal tumors: technical difficulties and rate of perforation. Endoscopy 2009; 41: 758-61.
Hori K, Uraoka T, Harada K et al. Predictive factors for technically difficult endoscopic submucosal dissection in the colorectum. Endoscopy 2014; 46: 862-70.
Hayashi N, Tanaka S, Nishiyama S et al. Predictors of incomplete resection and perforation associated with endoscopic submucosal dissection for colorectal tumors. Gastrointest Endosc. 2014; 79: 427-35.
Kim E, Kim K, Cho K et al. Factors predictive of perforation during endoscopic submucosal dissection for the treatment of colorectal tumors. Endoscopy 2011; 43: 573-8.
Imai K, Hotta K, Yamaguchi Y et al. Preoperative indicators of failure of en bloc resection or perforation in colorectal endoscopic submucosal dissection: implications for lesion stratification by technical difficulties during stepwise training. Gastrointest. Endosc. 2016; 83: 954-62.
Tanaka S, Oka S, Chayama K. Colorectal endoscopic submucosal dissection: present status and future perspective, including its differentiation from endoscopic mucosal resection. J. Gastroenterol. 2008; 43: 641-51.
Kudo S, Rubio CA, Teixeira CR, Kashida H, Kogure E. Pit pattern in colorectal neoplasia: endoscopic magnifying view. Endoscopy 2001; 33: 367-73.
Matsuda T, Fujii T, Saito Y et al. Efficacy of the invasive/non-invasive pattern by magnifying chromoendoscopy to estimate the depth of invasion of early colorectal neoplasms. Am. J. Gastroenterol. 2008; 103: 2700-6.
Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma, 3rd English edn. Tokyo: Kanehara Co., Ltd, 2019.
Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 2005; 37: 570-8.
Hotta K, Oyama T, Shinohara T et al. Learning curve for endoscopic submucosal dissection of large colorectal tumors. Dig. Endosc. 2010; 22: 302-6.
Ferlitsch M, Moss A, Hassan C et al. Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 2017; 49: 270-97.
Longcroft-Wheaton G, Duku M, Mead R, Basford P, Bhandari P. Risk stratification system for evaluation of complex polyps can predict outcomes of endoscopic mucosal resection. Dis. Colon. Rectum. 2013; 56: 960-6.
Hong SN, Byeon JS, Lee BI et al. Prediction model and risk score for perforation in patients undergoing colorectal endoscopic submucosal dissection. Gastrointest. Endosc. 2016; 84: 98-108.
Sakata S, McIvor F, Klein K, Stevenson ARL, Hewett DG. Measurement of polyp size at colonoscopy: a proof-of-concept simulation study to address technology bias. Gut 2018; 67: 206-8.
Isomoto H, Nishiyama N, Yamaguchi E et al. Clinicopathological factors associated with clinical outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms. Endoscopy 2009; 41: 679-83.
Yamasaki Y, Takeuchi Y, Uedo N et al. Efficacy of traction-assisted colorectal endoscopic submucosal dissection using a clip-and-thread technique: a prospective randomized study. Dig. Endosc. 2018; 30: 467-76.
Sakamoto N, Osada T, Shibuya T et al. The facilitation of a new traction device (S-O clip) assisting endoscopic submucosal dissection for superficial colorectal neoplasms. Endoscopy 2008; 40(Suppl 2): E94-5.
Mori H, Kobara H, Nishiyama N, Masaki T. Current status and future perspectives of endoscopic full-thickness resection. Dig. Endosc. 2018; 30(Suppl 1): 25-31.
Fuccio L, Hassan C, Ponchon T et al. Clinical outcomes after endoscopic submucosal dissection for colorectal neoplasia: a systematic review and meta-analysis. Gastrointest. Endosc. 2017; 86(1): 74-86.e17.

Auteurs

Kenichiro Imai (K)

Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.

Kinichi Hotta (K)

Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.

Sayo Ito (S)

Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.

Yuichiro Yamaguchi (Y)

Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.

Yoshihiro Kishida (Y)

Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.

Yohei Yabuuchi (Y)

Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.

Masao Yoshida (M)

Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.

Noboru Kawata (N)

Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.

Masaki Tanaka (M)

Division of Endoscopy, Shimane Prefectural Central Hospital, Shimane, Japan.

Naomi Kakushima (N)

Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.

Kohei Takizawa (K)

Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.

Hirotoshi Ishiwatari (H)

Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.

Hiroyuki Matsubayashi (H)

Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.

Keita Mori (K)

Clinical Trial Coordination Office, Shizuoka Cancer Center, Shizuoka, Japan.

Hiroyuki Ono (H)

Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH